AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Skills vary significantly among endoscopists, and a high miss rate is reported. Automated polyp segmentation can reduce the missed rates, and timely treatment is possible in the early stage. To ...

This book by the late R D Mindlin is destined to become a classic introduction to the mathematical aspects of two-dimensional theories of elastic plates. It systematically derives the two-dimensional ...

Bonus Oct 08, 2015 Oct 10, 2015 Aug 17, 2015 Bonus Ratio: 1 share(s) for every 8 shares held Bonus Jul 24, 2014 Jul 26, 2014 May 30, 2014 Bonus Ratio: 1 share(s) for every 5 shares held Captain ...